References
- Tsukasaki K, Ikeda S, Murata K, Maeda T, Atogami S, Sohda H, Momita S, Jubashi T, Yamada Y, Mine M, et al. Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma. Leuk Res 1993; 17: 157–166
- Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Br J Haematol 1991; 79: 428–437
- Tsukasaki K, Maeda T, Arimura K, Taguchi J, Fukushima T, Miyazaki Y, Moriuchi Y, Kuriyama K, Yamada Y, Tomonaga M. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature. Bone Marrow Transplant 1999; 23: 87–89
- Obama K, Tara M, Sao H, Taji H, Morishima Y, Mougi H, Maruyama Y, Osame M. Allogenic bone marrow transplantation as a treatment for adult T-cell leukemia. Int J Hematol 1999; 69: 203–205
- Borg A, Yin JA, Johnson PR, Tosswill J, Saunders M, Morris D. Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation. Br J Haematol 1996; 94: 713–715
- Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA, Jr., Miller TP. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002–1006
- Riddell S, Appelbaum FR, Buckner CD, Stewart P, Clift R, Sanders J, Storb R, Sullivan K, Thomas ED. High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia. J Clin Oncol 1988; 6: 576–582
- Kawa K, Nishiuchi R, Okamura T, Igarashi H. Eradication of human T-lymphotropic virus type 1 by allogeneic bone-marrow transplantation. Lancet 1998; 352: 1034–1035
- Kanda Y, Taketazu F, Chiba S, Yazaki Y, Hirai H. Persistent infection with human T lymphotropic virus type 1 after allogeneic bone marrow transplantation from a seronegative donor. Bone Marrow Transplant 1999; 24: 349
- Ljungman P, Lawler M, Asjo B, Bogdanovic G, Karlsson K, Malm C, McCann SR, Ringden O, Gahrton G. Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia. Br J Haematol 1994; 88: 403–405
- Kataoka R, Takehara N, Iwahara Y, Sawada T, Ohtsuki Y, Dawei Y, Hoshino H, Miyoshi I. Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits. Blood 1990; 76: 1657–1661
- Zanke BW, Rush DN, Jeffery JR, Israels LG. HTLV-1 T cell lymphoma in a cyclosporine-treated renal transplant patient. Transplantation 1989; 48: 695–697
- Tsurumi H, Tani K, Tsuruta T, Shirato R, Matsudaira T, Tojo A, Wada C, Uchida H, Ozawa K, Asano S. Adult T-cell leukemia developing during immunosuppressive treatment in a renal transplant recipient. Am J Hematol 1992; 41: 292–294
- Chen YC, Wang CH, Su IJ, Hu CY, Chou MJ, Lee TH, Lin DT, Chung TY, Liu CH, Yang CS. Infection of human T-cell leukemia virus type I and development of human T-cell leukemia lymphoma in patients with hematologic neoplasms: a possible linkage to blood transfusion. Blood 1989; 74: 388–394